Background -Diabetes mellitus (DM) 
INTRODUCTION
Diabetes Mellitus is the most common endocrinal disorder seen in clinical practice. The prevalence of diabetes mellitus in West is between 6-7.6 %. India has already become the "diabetes capital" of the world with over 3 crore affected patients. Between 1995 and 2025, there is predicted to be a 35% increase in the worldwide prevalence of diabetes. The rising number of people with diabetes will occur mainly in populations of developing countries, leading to more than 300 million people with diabetes globally by 2025 [1] .
Thyroid disorders are also very common in the general population and it is second only to diabetes mellitus as the most common condition to affect the endocrine system. As a result it is common for an individual to be affected by both thyroid diseases and diabetes. The first report showing the association between diabetes and thyroid dysfunction was published in 1979 [2, 3] .
Since then a number of studies have estimated the prevalence of thyroid dysfunction among diabetes patients to be varying from 2.2 to 17 %, the most common disorder being subclinical hypothyroidism [4, 5] . However, few studies have also estimated much higher prevalence of thyroid dysfunction in diabetes i.e. 31 % and 46.5% respectively [6, 7] . Thyroid function tests are especially recommended in patients with clinical suspicion and / or unexplained changes in diabetic metabolic control or serum cholesterol and weight gain. The treatment of hypothyroidism helps better control of other associated conditions. The ability to diagnose and treat unsuspected hypothyroidism in these patients may greatly enhance the quality of life. Hence the need to detect such cases where hypothyroidism contributes to morbidity and 
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where it is the cause for poor control of the associated conditions [1] . Table 2 shows the level of various laboratory parameters in diabetic and non-diabetic subjects. FPG and HbA1c were significantly higher in diabetic patients as compared to the non-diabetic subjects. The serum levels of T3, T4, FT3 and FT4 were significantly lower in diabetic subjects as compared to the non-diabetic subjects while level of serum TSH was significantly higher in diabetic subjects as compared to the non-diabetic subjects. Table 3 shows the distribution of thyroid disorder according to the gender in type II diabetes mellitus and non-diabetic control subjects. Out of the 80 type II diabetic subjects studied, 28.75% showed abnormal thyroid function (22.50% had hypothyroidism and 6.25% had hyperthyroidism) and 71.25% showed normal thyroid hormone level.
MATERIALS AND METHOD

RESULTS
The incidence of hypothyroidism was more in females as compared to the males in type II diabetes (Males 12.5 %, Females 32.50 %). Hypothyroidism was present in 22.50% patients, of which 13.75% had subclinical hypothyroidism and 8.75% had primary hypothyroidism.
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The results of the present study were in accordance with the reports of Suzuki et al [8] ,Smithson et al [9] , Celani et al [10] , Udiang et al [11] , Perros P et al [12] and Gray RS,Borsey DQ et al [13] who in separate studies found altered thyroid hormone level (both low and high) in a diabetic patient.
DISCUSSION
Effects of Thyroid Hormones on Glucose Homeostasis
Thyroid hormones affect glucose metabolism via several mechanisms. Hyperthyroidism has long been recognized to promote hyperglycaemia [14] .
During hyperthyroidism, the half-life of insulin is reduced most likely secondary to an increased rate of degradation and an enhanced release of biologically inactive insulin precursors [15, 16] .
Endogenous production of glucose is also enhanced in hyperthyroidism via several mechanisms [17, 18] .
It is well known that diabetic patients with hyperthyroidism experience worsening of their glycaemic control and thyrotoxicosis has been shown to precipitate diabetic ketoacidosis in subjects with diabetes [19, 20] .
As for hypothyroidism, glucose metabolism is affected as well via several mechanisms. A reduced rate of liver glucose production is observed in hypothyroidism and accounts for the decrease in insulin requirement in hypothyroid diabetic patients [21] .
A recent study involving subjects from a Chinese population found a higher TSH level in patients with metabolic syndrome compared to that in the non-metabolic syndrome group suggesting that subclinical hypothyroidism may be a risk factor for metabolic syndrome [22] .
Uncontrolled hyperthyroidism in diabetic patients may trigger hyperglycaemic emergencies while recurrent hypoglycaemic episodes have been reported in diabetic patients with hypothyroidism. Furthermore, thyroid dysfunction may amplify cardiovascular disease risk in diabetic patients through interrelationships with dyslipidaemia, insulin resistance and vascular endothelial dysfunction.
Effects of Diabetes Mellitus on Thyroid Hormones and Thyroid Diseases
Altered thyroid hormones have been described in patients with diabetes especially those with poor glycaemic control. In diabetic patients, the nocturnal TSH peak is blunted or abolished, and the TSH response to TRH is impaired [23] . Reduced T3 levels have been observed in uncontrolled diabetic patients. This "low T3 state" could be explained by impairment in peripheral conversion of T4 to T3 that normalizes with improvement in glycaemic control.
The abnormal thyroid hormone level may be the outcome of various medications that the diabetic patients were receiving. For example, it is known that insulin [24] , an anabolic hormone enhances the level of FT4 while it suppresses the level of T3 by inhibiting hepatic conversion of T4 to T3. On the other hand some of the oral hypoglycaemic agents such as the phenylthioureas are known to suppress the level of FT4 and T4, while causing raised levels of TSH [25, 26] .
CONCLUSION
The relationship between diabetes mellitus and thyroid disorders is characterized by a complex interdependent interaction. Furthermore, it seems that unidentified thyroid dysfunction could negatively impact diabetes and its complications. A higher frequency of retinopathy and nephropathy was observed in diabetic patients with subclinical hypothyroidism, and more severe retinopathy was noted [27, 28, 29] .
Therefore, management of subclinical hypothyroidism in patients with diabetes may prove beneficial. We conclude that a systematic 
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approach to thyroid testing in diabetic subjects is desirable; particularly in those patients whose associated conditions are difficult to manage. The treatment of hypothyroidism helps in better control of other associated conditions. The ability to diagnose and treat unsuspected hypothyroidism in these patients may greatly enhance the quality of life. Hence the need to detect such cases where hypothyroidism contributes to morbidity and where it is the cause for poor control of the associated conditions.
